Form D · Other Health Care

Javara Inc.

Winston Salem, NC · CIK 0001785338

Offering snapshot reported May 28, 2025 · SEC filing

Reported sold
$6.6M
Offering amount: $10M
Investors reported
23
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 13, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 28, 2025Initial$6,600,550No comparison23SEC filing
Nov 9, 2023Initial$9,430,000No comparison5SEC filing
Apr 12, 2022Initial$30,000,003No comparison2SEC filing
Sep 1, 2021Initial$5,285,109No comparison12SEC filing
Aug 19, 2020Initial$4,600,000No comparison11SEC filing
Aug 13, 2019Initial$3,775,600No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-547340

Source: Form D, filed May 28, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jennifer Byrne Director, Executive
Andrew Domescik Executive
Charles Hauser Director
Todd Johnson Director
Charles W (Todd) Johnson Director
Jeffrey Kasher Director
Linda Mccarty Executive
Thomas H. Pike Director
Gerald Roach Director
Erika Taurel Executive
John Vann Director
Josef Von Rickenbach Director
Joseph Von Rickenbach Director
Brett Zbar Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
450 N. Patterson Ave., Suite 400
Winston Salem, NC, 27101